Scot Michael Elder - 08 May 2025 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Reporting relationship: Chief Legl & Comp Off, CorpSec
Issuer ticker: TMCI
Reported as of: 08 May 2025
Net transaction value: -$14,281
SEC form: 4
Accepted by SEC: 12 May 2025, 17:30:05 UTC
Prior SEC filing: 11 Mar 2025
Next SEC filing: 12 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Lisa Taylor as Attorney-in-fact for Scot Elder

Key filing fact

Scot Michael Elder filed Form 4 for TREACE MEDICAL CONCEPTS, INC. (TMCI) on 12 May 2025.

Key facts

This page summarizes Scot Michael Elder's Form 4 filing for TREACE MEDICAL CONCEPTS, INC. (TMCI).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 12 May 2025, 17:30.

Change

Previous filing in this sequence was filed on 11 Mar 2025.
Current net transaction value: -$14,281.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001916619 Primary reporting owner

Elder Scot Michael

Relationship: Chief Legl & Comp Off, CorpSec
Address: C/O TREACE MEDICAL CONCEPTS, INC., 100 PALMETTO PARK PLACE, PONTE VEDRA
Signature: /s/ Lisa Taylor as Attorney-in-fact for Scot Elder
Signature date: 12 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TMCI transaction

Common Stock

Award

Transaction value: $0
Shares: +7,775
Change %: +1.4%
Price: $0.000000
Shares after: 578,558
Date: 08 May 2025
Ownership: Direct
Footnotes: F1, F2

TMCI transaction

Common Stock

Tax liability

Transaction value: $14,281
Shares: -1,894
Change %: -0.33%
Price: $7.54
Shares after: 576,664
Date: 08 May 2025
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents performance stock units ("PSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each PSU upon vesting. The PSUs vested upon the accomplishment of a performance goal related to enforcement of the Company's intellectual property rights.

Footnote F2

Includes 523,283 restricted stock units.